Julia Maués: This is excellent science communication
Julia Maués, Co-Founder of GRASP, shared a post by Monica Bertagnolli, adding:
“Not hidden in a long technical paper, the phrase ‘in a study in mice’ is upfront, loud, and clear.
This is excellent science communication!
Monica Bertagnolli leading by example National Institutes of Health.”
Quoting Monica Bertagnolli’s post:
“In a study in mice, researchers used a new epigenetic editor to silence prion protein in the brain, providing a path toward a treatment for neurodegenerative diseases caused by the toxic buildup of unwanted proteins. More on my blog.”
Sources: Julia Maués/X and Monica Bertagnolli/X
Monica Bertagnolli is the Director of the National Institute of Health (NIH), USA. She is the President of Alliance for Clinical Trials In Oncology Foundation. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology. In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Forum.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023